Most recent update: Thursday, November 21, 2019 - 11:01

Bariatric News - Cookies & privacy policy

You are here

gastro-oesophageal reflux disease

Effectiveness of gastric bypass on reflux symptoms overestimated

Although gastro‐oesophageal reflux symptoms do show a dramatic decline after gastric bypass surgery approximately half of patients required continuous anti‐reflux medication after surgery, according to researchers from Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. The study group therefore summarised that the treatment efficacy of gastric bypass on reflux could have been overestimated.

GERDx device a safe alternative to GERD treatment

European researchers have report that the GERDx system (G-SURG) - a recently launched endoscopic plication device that uses hydraulic elements for controlling - is a safe alternative to gastro-oesophageal reflux disease (GERD) treatment, according to the outcomes from a single centre study that included 40 patients.

EndoStim LES stimulation therapy is safe and efficacious

The interim results of an international multi-centre trial show that EndoStim’s neurostimulation minimally-invasive therapy device in patients with gastro-oesophageal reflux disease (GERD) insufficiently controlled by medication, demonstrated safety and efficacy leading to significant improvements in both GERD symptoms and patients' oesophageal acid exposure, the gold-standard biomarker for GERD, through six months of therapy. The study will continue through completion of patients' two-year post-therapy follow-ups.

LSG effective, but technique needs further exploration

Laparoscopic sleeve gastrectomy (LSG) is a safe and effective procedure but the operative technique needs further exploration to avoid post-procedure issue such as gastroesophageal reflux (GERD). The study, published by BioMed Central, also reported that majority of patients had resolution in several comorbidities following surgery.

TIF demonstrates effectiveness for GERD symptoms

Transoral Incisionless Fundoplication (TIF) is a safe and effective therapeutic option for carefully selected patients with chronic gastro-oesophageal reflux disease, according to the results of a registry published in the journal Surgical Laparoscopy Endoscopy and Percutaneous Techniques.

LSG does not relieve or resolve GERD

Laparoscopic sleeve gastrectomy does not resolve or relieve gastroesophageal reflux disease (GERD) and in some instances may actually contribute to reflux, according to the study by researchers from the Madigan Army Medical Center, Ft Lewis, WA.

"Bariatric surgery isn't one-operation-fits-all. It really needs to be tailored to the patient," said study author, Dr Matthew Martin. "Somebody who has significant reflux symptoms, or GERD, a sleeve may not be the best option for them, and it's certainly something that needs to be discussed before surgery.”

GERD: prompt pH monitoring test preferred to PPI use

More objective testing may substantially reduce the cost and risk of managing gastro-oesophageal reflux disease (GERD), according to a study presented at Digestive Disease Week in Orland, FL.

Researchers from New York Presbyterian Hospital and Weill-Cornell Medical College, reported that almost a third of patients undergoing treatment have no measurable signs of the chronic condition, and they projected cost-savings of up to US$7,300 per patient over ten years if current diagnostic guidelines were changed.

Males have more to gain from bariatric surgery, study claims

Men have more to gain from bariatric surgery, according to researchers from the University of California, Davis. In a review of 1,368 consecutive patients evaluated for bariatric surgery over a four-year period, men on average presented with 4.54 serious comorbidities and 3.70 complicated comorbidities, compared with women who presented with 4.15 serious comorbidities and 3.08 complicated comorbidities. 

Subscribe to RSS - gastro-oesophageal reflux disease